Nicotinamide
Every registration of this product has been cancelled.
Pyridine-3-carboxamide
Drag to rotate; arrow keys step through the atoms. Structure from PubChem CID 936.
Registration
- Applicants
- 1
- Registrations
- 2
Applicants and registrations
| Applicant | Brands | Dosages | Registrations | Schedule | Leaflets |
|---|---|---|---|---|---|
| The Premier Pharmaceutical Co LtdCancelled | Nicotinamide | 50 MG, 100 MG | H0549, H0550 | Not determined | None |
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Nicotinamide 50 MG tablets TABLET NICOTINAMIDE A 52,5 MG | 50 MGTablets | H0549 | Cancelled | Not determined | None |
| Nicotinamide 100 MG tablets TABLET NICOTINAMIDE A 100 MG | 100 MGTablets | H0550 | Cancelled | Not determined | None |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
Listings for this ingredient that could not be applied to this product
S1: Nicotinamide
- in oral preparations or mixtures containing more than 500 mg of Nicotinamide per recommended daily dose alone or in combination with other active pharmaceutical ingredients. (S0)
Consolidated Schedules 06 July 2026, lines 886 to 888
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
Background
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.